SCHEMBL4774973

SCHEMBL4774973

O=C(Cc1nc2ccccc2o1)Nc1cc(-c2cccnc2)nc(-c2ccccn2)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.46
ADRB1 P08588 1/20 0.46
ADRB3 P13945 1/20 0.46
SMN1; SMN2 Q16637 4/20 0.45
KDM4E B2RXH2 4/20 0.45
POLB P06746 3/20 0.45
ALDH1A1 P00352 4/20 0.44
HSD17B10 Q99714 3/20 0.44
HPGD P15428 2/20 0.44
USP2 O75604 2/20 0.44
ESR1 P03372 1/20 0.44
NPC1 O15118 5/20 0.43
RAB9A P51151 5/20 0.43
LMNA P02545 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C19 P33261 1/20 0.43
ADORA1 P30542 3/20 0.42
ADORA2A P29274 4/20 0.42
KMT2A Q03164 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4768829 0.91 KDM4E (0.44) ADRB2ADRB1ADRB3SMN1; SMN2KDM4E
SCHEMBL4768822 0.81 SMN1; SMN2 (0.60) SMN1; SMN2KDM4EALDH1A1HPGDNPC1
SCHEMBL4769062 0.80 ADRB2 (0.46) ADRB2ADRB3SMN1; SMN2KDM4EPOLB
SCHEMBL4773144 0.78 ADORA2A (0.47) SMN1; SMN2KDM4EALDH1A1HSD17B10HPGD
SCHEMBL4765953 0.77 LMNA (0.52) SMN1; SMN2ALDH1A1USP2NPC1RAB9A
SCHEMBL4766014 0.77 ADORA1 (0.47) SMN1; SMN2POLBALDH1A1NPC1RAB9A
SCHEMBL5024997 0.76 ADORA2A (0.53) CYP1A2CYP3A4ADORA1ADORA2A
SCHEMBL4776165 0.75 CCKBR (0.52) SMN1; SMN2POLBALDH1A1HSD17B10NPC1
SCHEMBL4770635 0.75 CYP1A2 (0.52) ADRB3SMN1; SMN2KDM4EALDH1A1USP2
SCHEMBL4775234 0.74 LMNA (0.49) SMN1; SMN2POLBALDH1A1USP2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1878733-A1 Pyrimidine derivatives as ALK-5 inhibitors Novartis AG (CH) 2008-01-16 EP disclosed